Cumulative prevalence (total infection days) for resistant parasites in simulations with no antimalarial drug treatment.</p
<p><b>Abbreviations</b>: JE, Jeffery-Eyles; CG, Carter & Graves; CQ, chloroquine; ACT, artemisinin-b...
This provides the data and code to estimate the frequency of parasites resistant to the antimalarial...
Understanding the evolution of drug resistance in malaria is a central area of study at the interse...
Using results from the simulations shown in Fig 9B(i-ii), we compared the densities of resistant par...
The proportions of infections falling into each category (single and mixed) are shown above the box-...
Panels A–I vary in treatment rate (daily probability of infected host starting treatment) and fitnes...
Malaria case counts and vector control interventions over time at 10 sites that have not received IR...
T the rate () and resistant infections at the rate , where is the happenings rate (see text) and is ...
<p>Force of infection (: new infections prior to any treatment per person year) against the probabil...
Results are shown for low-transmission (b = 5) and high-transmission (b = 15) settings with high or ...
Parasite prevalence according to Mahajanga districts (P-values in S2, S3 and S4 Tables).</p
<p>Measured prevalence against force of infection (: new infections prior to any treatment per perso...
<p>Durations (A,C,E) and peak parasite counts (B,D,F) from malariatherapy dataset for the Santee Coo...
Drug resistance spreads through a population because (i) parasites can survive direct treatment and/...
A deterministic mathematical model which predicts the probability of developing a new drug-resistant...
<p><b>Abbreviations</b>: JE, Jeffery-Eyles; CG, Carter & Graves; CQ, chloroquine; ACT, artemisinin-b...
This provides the data and code to estimate the frequency of parasites resistant to the antimalarial...
Understanding the evolution of drug resistance in malaria is a central area of study at the interse...
Using results from the simulations shown in Fig 9B(i-ii), we compared the densities of resistant par...
The proportions of infections falling into each category (single and mixed) are shown above the box-...
Panels A–I vary in treatment rate (daily probability of infected host starting treatment) and fitnes...
Malaria case counts and vector control interventions over time at 10 sites that have not received IR...
T the rate () and resistant infections at the rate , where is the happenings rate (see text) and is ...
<p>Force of infection (: new infections prior to any treatment per person year) against the probabil...
Results are shown for low-transmission (b = 5) and high-transmission (b = 15) settings with high or ...
Parasite prevalence according to Mahajanga districts (P-values in S2, S3 and S4 Tables).</p
<p>Measured prevalence against force of infection (: new infections prior to any treatment per perso...
<p>Durations (A,C,E) and peak parasite counts (B,D,F) from malariatherapy dataset for the Santee Coo...
Drug resistance spreads through a population because (i) parasites can survive direct treatment and/...
A deterministic mathematical model which predicts the probability of developing a new drug-resistant...
<p><b>Abbreviations</b>: JE, Jeffery-Eyles; CG, Carter & Graves; CQ, chloroquine; ACT, artemisinin-b...
This provides the data and code to estimate the frequency of parasites resistant to the antimalarial...
Understanding the evolution of drug resistance in malaria is a central area of study at the interse...
DOI
Add to ORKG